Considering these features, the following new treatment strategy was attempted: Cyclic dinucleotides (CDNs) bonded to STING (which had been altered to prevent degradation by DNase) were introduced into the tumor of a melanoma mouse model. This evidence concerns the gene STING1 and melanoma.